Publicacions científiques

Quispialaya KM, Therriault J, Aliaga A, Zimmermann M, Fernandez-Arias J, Lussier F, Massarweh G, Pascoal T, Soucy JP, Gauthier S, Jean-Claude B, Gilfix B, Vitali P, Rosa-Neto P.

Any publicació:

2022

Número de revista:

Neurology vol. 99 n. 22

https://n.neurology.org/content/99/22/e2428

Article

Discordance Between Perceptions and Experience of Lumbar Puncture: A Prospective Study

Autor/s:

Umemura Y, Khan B, Weill BJ, Buthorn JJ, Skakodub A, Ridder AJ, Nevel KS, Sun Y, Boire A

Any publicació:

2022

Número de revista:

Neurology® Clinical Practice vol. 12 n. 5

https://cp.neurology.org/content/12/5/344

Comentari

Discrimination as one of the social plights facing people with pain.

Autor/s:

Karos K.

Commentary

Any publicació:

2022

Número de revista:

Pain vol. 163 n. 2

https://journals.lww.com/pain/Fulltext/2022/02000/Discrimination_as_one_of_the_s…

Article

Discriminatory Capacity of the Physical Domain Versus the Full-Scale Pediatric Quality of Life Inventory With Traumatic Brain Injury Severity in Children.

Autor/s:

Benipal S, Kuppermann N, Tancredi DJ, Rivara FP, Wang J, Nishijima DK.

Brief Report

Any publicació:

2022

Número de revista:

American Journal of Physical Medicine & Rehabilitation. vol. 101 n. 5

https://journals.lww.com/ajpmr/Fulltext/2022/05000/Discriminatory_Capacity_of_th…

Article

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.

Autor/s:

Roos I, Malpas C, Leray E, Casey R, Horakova D, Havrdova EK, Debouverie M, Patti F, De Seze J, Izquierdo G, Eichau S, Edan G, Prat A, Girard M, Ozakbas S, Grammond P, Zephir H, Ciron J, Maillart E, Moreau T, Amato MP, Labauge P, Alroughani R, Buzzard K, Skibina O, Terzi M, Laplaud DA, Berger E,...

Any publicació:

2022

Número de revista:

Neurology vol. 99 n. 17

https://n.neurology.org/content/99/17/e1926

Article

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.

Autor/s:

Majbour N, Aasly J, Abdi I, Ghanem S, Erskine D, van de Berg W, El-Agnaf O.

Any publicació:

2022

Número de revista:

Neurology vol. 99 n. 21

https://n.neurology.org/content/99/21/e2417

Article

Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.

Autor/s:

Paakinaho A, Koponen M, Tiihonen M, Kauppi M, Hartikainen S, Tolppanen AM.

Any publicació:

2022

Número de revista:

Neurology vol. 98 n. 12

https://n.neurology.org/content/98/12/e1273

Article

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival.

Autor/s:

Ng HS, Zhu F, Kingwell E, Yao S, Ekuma O, Evans C, Fisk JD, Marrie RA, Zhao Y, Tremlett H.

Any publicació:

2022

Número de revista:

Neurology Neuroimmunology & Neuroinflammation vol. 9 n. 5

https://nn.neurology.org/content/9/5/e200005

Una iniciativa de:

Cercador

Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions.

Discharge Rehabilitation Measures Predict Activity Limitations in Patients With Stroke 6 Months After Inpatient Rehabilitation.

Discordance and Concordance Between Cerebrospinal and [18F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases.

Discordance Between Perceptions and Experience of Lumbar Puncture: A Prospective Study

Discrimination as one of the social plights facing people with pain.

Discriminatory Capacity of the Physical Domain Versus the Full-Scale Pediatric Quality of Life Inventory With Traumatic Brain Injury Severity in Children.

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.

Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival.

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!